Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > SS-31 for Sale > SS-31 Elamipretide Peptide High Purity 99% for Mitochondrial Research Use
SS-31 Elamipretide Peptide High Purity 99% for Mitochondrial Research Use buy - large image1
SS-31 Elamipretide Peptide High Purity 99% for Mitochondrial Research Use buy - image1

SS-31 Elamipretide Peptide High Purity 99% for Mitochondrial Research Use

Unit Price: Get Latest Price
Grade:

Pharmaceutical Grade

Content:

99%

Port:

Guang Zhou

Brand:

SS-31

Packaging:

10mg*10vials 30mg*10vials 50mg*10vials

Price valid (until):

2026-08-28

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Qualification:
Main Products:

beaty prodt

  • Product Description

  • Seller Information

  • Description


      Product Detail  


    Send your message to us

    Our contact information:+852 6252 0146

    Email: 19076005092@163.com or 2580597795@qq.com


    Product Name: SS-31 

    Purity: ≥99%

    Appearance: White to off-white lyophilized powder

    Solubility: Soluble in water

    Storage: -20°C, protected from light, sealed

    Packaging Specifications: 10mg×10 vials / 30mg×10 vials / 50mg×10 vials

    Description:
    SS-31 (also known as Elamipretide or MTP-131) is a mitochondria-targeted tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂, where Dmt is 2,6-dimethyl-L-tyrosine). It selectively targets the inner mitochondrial membrane by binding to cardiolipin, a phospholipid essential for mitochondrial function. This binding stabilizes cardiolipin, maintains mitochondrial membrane integrity, reduces reactive oxygen species (ROS) production, and increases ATP generation. SS-31 also prevents the opening of the mitochondrial permeability transition pore, which is associated with mitochondrial stress.

    SS-31 is widely studied in research on mitochondrial dysfunction, neuroprotection, neurodegenerative diseases (including Alzheimer's disease and Parkinson's disease), cardiovascular diseases, muscle disorders, and inflammation-related conditions. It has been shown to cross the blood-brain barrier and accumulate in the inner mitochondrial membrane at concentrations over 5000 times higher than in the cytoplasm.

    Application: For biochemical research and laboratory use only. Not for human consumption or therapeutic use.

    Note: The price shown is for reference only. Please contact us for accurate pricing on different pack sizes. Volume discounts are available for large orders.

    Items Specifications
    SS-31  10mg×10 vials
    SS-31  30mg×10 vials
    SS-31  50mg×10 vials

    Basic Info
    Product Name:

    SS-31

    Categories:

    Polypeptide

    Research
    Class:

    Mitochondria-targeted tetrapeptide (Szeto-Schiller peptide)

    Status:

    FDA-approved (Forzinity) — Accelerated Approval 2025

    Mechanism:

    A cell-permeable, synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) that selectively concentrates in the inner mitochondrial membrane and reversibly binds to cardiolipin, a phospholipid essential for electron transport chain (ETC) function. By stabilizing cardiolipin, SS-31 restores mitochondrial bioenergetics, reduces cytochrome c peroxidase activity, and prevents oxidative damage in cells with impaired mitochondrial function.

    Activity note:

    SS-31 does not act via traditional receptor agonism. It binds cardiolipin with high selectivity in the inner mitochondrial membrane. Functional EC₅₀ values are context-dependent (cell type, stress model). Key electrophysiology studies report mitochondrial membrane potential restoration at nanomolar concentrations.

    Source:

    Szeto HH, et al. AAPS J. 2006;8(2):E277-E283. Birk AV, et al. J Am Soc Nephrol. 2014;25(6):1157-1169.DOI

    Clinical Development:

    NCT03098797; NCT02814097; NCT02976038; NCT03354065

    FDA:

    Forzinity (approved 2025-09-19)

    References
    ChEMBL:

    CHEMBL3833370

    DrugBank:

    DB11981

    KEGG DRUG:

    D10925

    PubChem:

    PubChem

    Disclaimer:

    Elamipretide (Forzinity) is FDA-approved under accelerated approval for Barth syndrome. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    beaty prodt

    Location:

    Room 1664, 3rd Floor, No. 1-2, East Lane, Yuancun Sanheng Road, Tianhe District, Guangzhou City

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    11-50

    Year of Establishment:

    2026

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.